Pear Bio
PrivateLast Round
Series A
May 14, 2023
Total Funding Raised
$19.6M
Company Overview
Pear Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in May 2023.
Pear Bio is a biotechnology company that provides a computational biology platform to guide personalized cancer treatment and drug discovery using 3D cell cultures and computer vision.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Computer Vision
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pear Bio Comparables
Compare Pear Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xilis | 88% | |
| Curesponse | 85% | |
| Vivodyne | 82% |
For institutional investors. Book with your work email.
Pear Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 14, 2023 | ||||
| Seed | Sep 27, 2021 | ||||
| Accelerator | Oct 10, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pear Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hoxton Ventures | Pre Seed, Seed, Series A |
| Fly Ventures | Seed, Series A |
| Crista Galli Ventures | Pre Seed, Seed, Series A |
| RebelBio | Accelerator |
| SOSV | Seed, Accelerator, Series A |
| Octopus Ventures | Series A |
| The Compound Capital Fund | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 62% MoM.
For institutional investors. Book with your work email.
Pear Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pear Bio's valuation, stock price, and market status.
Is Pear Bio a public or private company?
Pear Bio is a private company.
What is the current stock price of Pear Bio?
Pear Bio is a private company, so its shares have no public market price. Caplight tracks Pear Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pear Bio worth (valuation)?
Valuation information for Pear Bio is not publicly available.
Can I buy Pear Bio stock?
Pear Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pear Bio's last funding round?
Pear Bio's most recent funding round was Series A on May 14, 2023.
Who are the main investors in Pear Bio?
Key investors in Pear Bio include Octopus Ventures.
Will Pear Bio IPO soon?
No public IPO plans have been announced for Pear Bio.
How can I track Pear Bio secondary market activity?
Caplight tracks bids, offers, and trades in Pear Bio's shares on secondary markets.